Bernstein initiated coverage on six pharma stocks, naming Zydus Lifesciences as its top pick, as the international brokerage holds a positive view on the Indian healthcare sector due to multiple tailwinds. In its latest note, Bernstein gave an ‘Outperform’ rating to the shares of Zydus Lifesciences, Lupin and Sun Pharma. It rated Aurobindo Pharma as…
Sector outperformer, Torrent Pharmaceuticals, has delivered 1-year returns of 16. It has another 14% upside, says this brokerage. Company’s PAT rose 16% YoY while its revenue increased 9% over the corresponding quarter of the last financial year.Buy Sun Pharma at Rs 1,805 | Target: Rs 1,968 | Upside: 9%Sun Pharmaceutical Industries’ 12-month returns stand at…
November 12, 2025November 12, 2025 Shares of Lupin Ltd were trading in the green and 2% higher on 12 November after the subsidiary of the company commissioned an Oncology block. In its regulatory filing, the company said that its wholly owned subsidiary, Lupin Manufacturing Solutions (LMS), commissioned a dedicated…
Lupin shares are currently trading at Rs 1,979.70 and have been consolidating over the past few months, signaling a healthy base-building phase. On the daily timeframe, the stock is showing early signs of a reversal and is on the verge of breaking out from a falling trend line that has acted as a key resistance…
Axis Securities has set a target price of Rs 2,500 on Lupin, showing an upside potential of around 27% from the current market prices. “New launches in the U.S. market, such as Darunavir and Spiriva, have gained market shares of up to 30% and 25%, respectively. The recent approval for gMegabran has the potential to…
April 1, 2025April 1, 2025 India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of innovation, cutting-edge research, and a drive to improve healthcare worldwide—making them a force to be reckoned with. In this…
In the five trading sessions prior to March 7, the Sensex rose by around 1.5%, or 1,134 points, closing at 74,333. The market ended on a positive note in 2 of those five sessions. ETMarkets highlighted seven stocks from the BSE 100 index that consistently saw price gains during this period. (Data Source: ACE Equity)…
Axis Securities has an overweight call on Lupin with a target price of Rs 2600. The current market price of Lupin is Rs 2160. Lupin, incorporated in 1983, is a Large Cap company with a market cap of Rs 99094.85 crore, operating in the pharmaceuticals sector. Lupin’s key products/revenue segments include Pharmaceuticals, Other Services, Export…
Indian Railway Finance Corporation Share Price 181.05 03:59 PM | 26 Aug 2024 -2.36(-1.29%) One97 Communications Share Price 530.4 03:59 PM | 26 Aug 2024 -24.46(-4.41%) YES Bank Share Price 24.08 03:59 PM | 26 Aug 2024 -0.32(-1.28%) ITC Share Price 505.7 03:59 PM | 26 Aug 2024 -0.11(-0.02%) HDFC Bank Share Price 1639.95 03:59…
June 17, 2024June 17, 2024 Pharmaceutical major Lupin Limited plans to increase its contract manufacturing business for its international clients and has appointed a new CEO. They have appointed Abdelaziz Toumi as the Chief Executive Officer of the company’s subsidiary, Lupin Manufacturing Solutions (LMS), which is a unit that…